In the Original Investigation titled “Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial,” published online December 14, 2020,1 the 14th author’s first name was misspelled. Dr Adams’s name should be spelled “Jamie Adams.” The status of this article has also been changed to open access under a CC-BY license. This article was corrected online.
References
- 1.Simuni T, Fisk B, Merchant K, et al; the Parkinson Study Group NILO-PD Investigators and Collaborators. Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial. JAMA Neurol. Published online December 14, 2020. doi: 10.1001/jamaneurol.2020.4725 [DOI] [PMC free article] [PubMed] [Google Scholar]